If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Execution of Cambay SPA

10 Jun 2021 12:05

RNS Number : 5179B
Oilex Ltd
10 June 2021
 

 

ASX-RNS Announcement

 

 

10 June 2021

 

ASX: OEX

AIM: OEX

Execution of Cambay SPA

 

Oilex Ltd (the Company) is pleased to announce that, further to recent announcements, the conditional binding sale and purchase agreement to acquire GSPC's 55% participating interest (PI) in the Cambay Production Sharing Contract (Cambay) (the Acquisition) has now been executed by both parties.

 

The ratification of the Acquisition by the Government of India is expected to occur in the coming months, which is the last outstanding condition to completion of the Acquisition Following completion of the previously announced equity raise, and shareholder approval provided on 8 June 2021, Oilex is currently securing a bank guarantee for the US$2.2 million consideration payable for the Acquisition.

 

The Acquisition will provide Oilex with 100% PI in the Cambay PSC. The primary interest in the PSC is the proven gas accumulation in the EP-IV tight siltstone reservoir, which has been produced historically by the Company at low rates from a number of wells within the PSC. Oilex has undertaken extensive technical studies on the asset and the Company's drilling plans in relation to a pilot program are well advanced, subject to finalisation of funding alternatives, with the aim of establishing flow rates after hydraulic stimulation of the Eocene siltstone reservoir.

 

The pilot program will implement the recommendations from a 2017/18 Baker Hughes-GE study focussed on drilling and stimulation using world-wide best practice. Any initial hydrocarbon production from these wells will utilise the existing Cambay processing and storage facilities and the connection to a local low pressure gas pipeline. Given success, the production facilities will be upgraded on an as required basis to provide a low-cost path to commercialise increased gas flows resulting from additional production wells.

 

The ultimate project aim is to aggregate sufficient production volumes from multiple wells to connect to the high-pressure pipeline system which will offer greater offtake stability and improved gas prices. It is anticipated that the results of the pilot program will provide the necessary data to determine whether horizontal wells can deliver an estimated 3 to 5 fold increase on well productivity, thereby offering the highest commercial returns for the project in order to exploit the third party gross contingent resource estimate of 926 BCF of gas and 61 million barrels of condensate (RISC 2015).

 

Oilex's Managing Director, Mr Joe Salomon, said:

 

"Finalisation of this transaction marks an important milestone in re-establishing access to high potential gas production at the Cambay gas field and positions the Oilex, once more, as an active Indian energy company. Oilex remains one of the few international companies active in the sector in India where we see enormous potential both for gas projects as well as renewable energy and carbon abatement projects. During the next few months, we will determine the Company's optimal participation level in the project and re-commence operational activities. Over the past few years, we have continued to review additional projects while also continuing to progress our UK assets. As a result, from this stronger platform we see opportunities to build on Oilex's current project inventory. I would like to take this opportunity to thank our staff and stakeholders who have maintained support for the Company as it has navigated these challenges."

 

 

 

For and on behalf of Oilex Ltd

 

 

Joe Salomon

Managing Director

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Consulting

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigoconsulting.com

chris.mcmahon@vvigoconsulting.com

Tel:+ 44 20 7390 0230 UK

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQDKKBKDBKDQAD
Date   Source Headline
7th Aug 20209:32 amRNSTermination of JPDA Arbitration Proceedings
31st Jul 202011:07 amRNSJune 2020 Quarterly Report
31st Jul 202010:45 amRNSLoan Restructure and Equity Issue
30th Jul 20209:00 amRNSManaging Director Contract Extension
27th Jul 20207:00 amRNSWest Kampar Update
17th Jul 20207:07 amRNSIssue of Securities
30th Jun 202010:40 amRNSSuccessful Bid for Cooper Basin Permit
30th Jun 20208:17 amRNSResults of General Meeting
30th Jun 20208:11 amRNSExecutive Director Contract Extension
30th Jun 20208:05 amRNSChange of Registered Office
29th Jun 20207:00 amRNSIndia Update
15th Jun 202010:28 amRNSChange to Notice of Meeting
15th Jun 20207:56 amRNSArmour Share Purchase Agreement
5th Jun 202011:52 amRNSExtension to Armour Agreement
3rd Jun 20201:14 pmRNSNotice of Change of Interest of Substantial Holder
1st Jun 20207:15 amRNSExtension to Armour Agreement
29th May 20207:00 amRNSNotice of General Meeting
27th May 20209:28 amRNSSale of Cooper Eromanga Basin Assets
26th May 20207:00 amRNSNotice of Change of Interest of Substantial Holder
15th May 20207:00 amRNSIssue of Securities
6th May 20207:00 amRNSAppendix 3Z B Lingo
6th May 20207:00 amRNSReplacement Appendix 5B
5th May 20208:36 amRNSBoard Changes
30th Apr 20209:16 amRNSMarch 2020 Quarterly Report
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 202011:02 amRNSCooper Basin Update
27th Apr 20207:14 amRNSCorrection: Variation to Financing Terms
23rd Apr 20201:45 pmRNSVariation to Financing Terms
3rd Apr 20207:00 amRNSChairman Consulting Contract Extension
3rd Apr 20207:00 amRNSExtension for Acquisition of Cooper Licences
26th Mar 20207:32 amRNSAppendix 3X Mark Bolton
26th Mar 20207:00 amRNSBoard and Executive Changes
24th Mar 20207:30 amRNSDoriemus Transaction - Update
16th Mar 20207:15 amRNSInterim Report 31 December 2019
16th Mar 20207:00 amRNSBusiness and Financial Restructure
12th Mar 20207:00 amRNSDoriemus Shareholders Approve Transaction
6th Mar 20207:15 amRNSOpportunity to Participate in Doriemus Offer
3rd Mar 202012:24 pmRNSUpdate on Cambay Sale Process
28th Feb 20209:29 amRNSExtension for Acquisition of Cooper Basin Licences
21st Feb 20207:30 amRNSStrong Funding Support for Cooper-Eromanga
11th Feb 20207:00 amRNSChairman Consulting Contract Extension
4th Feb 20207:00 amRNSAppendix 3B: Issue of Securities
3rd Feb 20202:23 pmRNSNew Series C Loan Facility
31st Jan 20208:17 amRNSDecember 2019 Quarterly Report
30th Jan 20207:00 amRNSDOR - Prop Acqn of Major Cooper-Eromanga Portfolio
29th Jan 202010:39 amRNSSale of Cooper Eromanga Basin Assets
28th Jan 20207:00 amRNSSale of Participating Interest in Bhandut
17th Jan 20202:05 pmRNSUpdate on Cambay Sale Process
7th Jan 20207:34 amRNSNotice of Change of Interest of Substantial Holder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.